microneedle semaglutide Daewoong initiates clinical trial assessing patch loaded with GLP-1 WeightCares 3 Daewoong's semaglutide microneedle patch hits

The anti-inflammatory properties of BPC-157 help reduce oxidative stress and regulate immune responses

All procedures involving human participants were conducted in accordance with the principles of the Declaration of Helsinki

This study, published in The Lancet , is the first randomised controlled trial investigating if GLP-1s can reduce alcohol intake in patients with obesity who are seeking treatment for alcohol use disorder

Given that several further dual agonists are coming closer to becoming licenced, such as mazdutide and survodutide, with many more in development [15], combining licenced dual agonists with developing mono-agonists may be a faster way to develop effective treatments achieving triple agonism